Myocardial Infarction/Acute Coronary Syndromes Flashcards
MI/CAS
Contributing to the leading cause of death in adults in the United States
Sudden cardiac death: one, coronary artery disease, and two, cardiomyopathies
MI signs/symptoms
1/3 of patients giving history of alteration in typical anginal pain Most infections occur at restColon pain similar to angina but more severe Nitroglycerin has little effect Cold sweats; weakness Impending doom Apprehension Lightheadedness Syncope Dyspnea Cough Nausea and vomiting
MI physical findings
Dysrhythmia common S4 very common Wheezing Pulmonary crackles Low-grade fever during first 48 hours Tachycardia
MI lab/diagnostics
EKG changes almost always; note 30% of patients have no initial EKG changes
Peaked T waves, ST elevations, Q wave development (30%-50% of patients do not have it)
Cardiac enzymes elevations above normal within 4 to 6 hours troponin I, CK Dash MB and remain high for several days
Echocardiogram
Leukocytosis 10–20 on the second day
Monitor for specific heart blocks
Lateral Infarct
I, aVL
Inferior Infarct
II,III, aVF
Anterior Infarct
V leads, or V3 and V4
1st degree AV block
PR interval >0.20 seconds
Type 1 2nd° AV block (winky Bach or Mobitz type one)
The PR interval gradually gets longer until a QRS complex is dropped
Type 2 2nd° AV block (Mobitz type two)
The atrial rhythm is regular, the PR interval is constant, but the ventricular rhythm is irregular; dropped QRS complexes occur
3rd° AV block
The atrial and ventricular rhythm are regular, PR interval varies with no regularity, the P and R waves can walk across the strip in rhythm, some P waves may be buried and QRS complex or T-wave; no relationship between the P-wave and the QRS complex
MI Management
Aspirin 325 mg tablet to chew
Nitroglycerin sublingual every five minutes times three
Begin O2 therapy; IV access
12 lead EKG and cardiac monitor
Morphine 2–4 mg IV
Furosemide of pulmonary edema presents 40 mg IVP
If not contraindicated, consider 5 mg metoprolol IV times three doses at two minute intervals, then 50 mg orally every six hours starting 15 minutes after the last IV dose
Ace inhibitors are most beneficial when the patient has failure or a large infarction to help prevent ventricular remodeling
Heparin versus low molecular weight heparin
Monitor therapeutic coagulation values
INR
Normal 0.8-1.2
MI 2.5 - 3.5 x normal
Coumadin 2-3
Activated Coagulation Time (ACT)
Normal 70-120 sec
150-190 or >300 sec post PTCA/stent
Activated Partial Thromboplastin Time (aPTT)
Normal 28-38 sec
Therapeutic values 1.5-2.5 x normal
PT
Normal 11-16 sec
Therapeutic 1.5-2.5 x normal
PTT
Normal 60-90 sec
Thera 1.5-2.5 x normal
Indications for pharmacologic revascularization
Unrelieved chest pain greater than 30 minutes and less than six hours with
ST segment elevation greater than 0.1 MV in two or more contingent leads
Contraindications for pharmacologic revascularizations
Prior ICH
Structural cerebral vascular lesion or malignant intracranial neoplasm
Ischemic stroke within three months
Suspected aortic dissection
Active bleeding or bleeding diathesis
Significant closed head trauma or facial trauma within three months
Intracranial or intra-spinal surgery within two months
Severe uncontrolled hypertension greater than 185/110
Active bleeding or risk thereof including a normal coagulation values